Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision history now includes a new entry for v3.5.0 and removes the previous v3.4.3 entry.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision v3.4.3 appears in the history, replacing the previous v3.4.2.SummaryDifference0.1%

- Check49 days agoChange DetectedThe Study Record History now includes a new revision entry v3.4.2, replacing the previous v3.4.1 revision. This appears to be a minor update to the revision metadata rather than a change to study data.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry added: v3.4.1 to the history. The prior Notice about government funding and the earlier revision v3.4.0 are shown as deletions in the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check63 days agoChange DetectedA site-wide notice about a lapse in government funding was added, warning that information may not be up to date and that transactions may not be processed, with references to cc.nih.gov and opm.gov for status updates.SummaryDifference0.8%

- Check70 days agoChange DetectedThe page history adds a Show glossary option and green/red highlights to indicate additions and deletions, plus revision notes (e.g., Revision: v3.4.0) and No FEAR Act data indicators. These display-only changes improve readability without altering the underlying study information.SummaryDifference1%

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.